Ani Pharmaceuticals (ANIP) Gross Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Gross Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | 164.00 |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 156.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -1,039.00 |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | 250.00 |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 316.00 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -1,747.00 |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | -235.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 124.00 |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | 598.00 |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -235.00 |
| Mar 31, 2026 | -236.00 |
| Dec 31, 2025 | 154.00 |
| Sep 30, 2025 | 153.00 |
| Jun 30, 2025 | 650.00 |
| Mar 31, 2025 | -128.00 |
| Dec 31, 2024 | -155.00 |
| Sep 30, 2024 | -604.00 |
| Jun 30, 2024 | -552.00 |
| Mar 31, 2024 | -46.00 |
| Dec 31, 2023 | -203.00 |
| Sep 30, 2023 | 276.00 |
| Jun 30, 2023 | 1,151.00 |
| Mar 31, 2023 | 1,784.00 |
| Dec 31, 2022 | 1,709.00 |
| Sep 30, 2022 | 765.00 |
| Jun 30, 2022 | -190.00 |
| Mar 31, 2022 | -1,650.00 |
| Dec 31, 2021 | -1,277.00 |
| Sep 30, 2021 | -892.00 |